Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3717)
All Articles published online
|
Jun 7, 2010 (publication date) through Jan 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vermeire S, Van Assche G, Rutgeerts P. Role of genetics in prediction of disease course and response to therapy. World J Gastroenterol 2010; 16(21): 2609-2615 [PMID: 20518082 DOI: 10.3748/wjg.v16.i21.2609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i21/2609.htm |
| Number | Citing Articles |
| 1 |
Oliver Gouldthorpe, Anthony G. Catto-Smith, George Alex. Biologics in Paediatric Crohn's Disease. Gastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/287574
|
| 2 |
Konstantinos H Katsanos, Konstantinos A Papadakis. Pharmacogenetics of Inflammatory Bowel Disease. Pharmacogenomics 2014; 15(16): 2049 doi: 10.2217/pgs.14.154
|
| 3 |
Walter Reinisch, Andrew R. Reinink, Peter D.R. Higgins. Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2015; 13(4): 635 doi: 10.1016/j.cgh.2014.03.037
|
| 4 |
Marília L. Cravo, Paula A. Ferreira, Patricia Sousa, Paula Moura-Santos, Sónia Velho, Lurdes Tavares, João R. de Deus, Paula Ministro, Paula Peixe, Luis A. Correia, José F. Velosa, Rui F. Maio, Miguel Brito. IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology 2014; 26(1): 26 doi: 10.1097/MEG.0000000000000004
|
| 5 |
Sima Barmania. Are doctors being overly scrutinized by the media?. British Journal of Hospital Medicine 2011; 72(3): 174 doi: 10.12968/hmed.2011.72.3.174a
|
| 6 |
Konstantinos Papamichael, Ann Gils, Paul Rutgeerts, Barrett G. Levesque, Séverine Vermeire, William J. Sandborn, Niels Vande Casteele. Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD. Inflammatory Bowel Diseases 2015; 21(1): 182 doi: 10.1097/MIB.0000000000000202
|
| 7 |
Marilia Cravo, Paula Ferreira, Patricia Sousa, Paula Moura-Santos, Sonia Velho, Lurdes Tavares, João Ramos Deus, Paula Ministro, João Pereira da Silva, Luis Correia, Jose Velosa, Rui Maio, Miguel Brito. Clinical and genetic factors predicting response to therapy in patients with Crohn's disease. United European Gastroenterology Journal 2014; 2(1): 47 doi: 10.1177/2050640613519626
|
| 8 |
M. A. Cozijnsen, J. N. Samsom, L. de Ridder. Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability. Pediatric Drugs 2018; 20(1): 19 doi: 10.1007/s40272-017-0266-9
|
| 9 |
Carolin Knecht, Christoph Fretter, Philip Rosenstiel, Michael Krawczak, Marc-Thorsten Hütt. Distinct metabolic network states manifest in the gene expression profiles of pediatric inflammatory bowel disease patients and controls. Scientific Reports 2016; 6(1) doi: 10.1038/srep32584
|
| 10 |
Karen van Hoeve, Ilse Hoffman, Severine Vermeire. Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease. Expert Opinion on Drug Safety 2018; 17(2): 185 doi: 10.1080/14740338.2018.1413090
|
| 11 |
Yukinori Okada, Keiko Yamazaki, Junji Umeno, Atsushi Takahashi, Natsuhiko Kumasaka, Kyota Ashikawa, Tomomi Aoi, Masakazu Takazoe, Toshiyuki Matsui, Atsushi Hirano, Takayuki Matsumoto, Naoyuki Kamatani, Yusuke Nakamura, Kazuhiko Yamamoto, Michiaki Kubo. HLA-Cw*1202-B*5201-DRB1*1502 Haplotype Increases Risk for Ulcerative Colitis but Reduces Risk for Crohn's Disease. Gastroenterology 2011; 141(3): 864 doi: 10.1053/j.gastro.2011.05.048
|
| 12 |
L. Kunovsky, Z. Kala, F. Marek, J. Dolina, K. Poredska, L. Kucerova, K. Benesova, L. Mitas. The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn’s disease. International Journal of Colorectal Disease 2019; 34(2): 347 doi: 10.1007/s00384-018-3122-7
|
| 13 |
Emilio G Quetglas, Zlatan Mujagic, Simone Wigge, Daniel Keszthelyi, Sebastian Wachten, Ad Masclee, Walter Reinisch. Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World Journal of Gastroenterology 2015; 21(44): 12519-12543 doi: 10.3748/wjg.v21.i44.12519
|
| 14 |
Andrew Simkus, Kristen D. Holtz, Eric C. Twombly. An intersectionality framework for identifying relevant covariates in health equity research. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1286121
|
| 15 |
Pavine L. C. Lefevre, Lisa M. Shackelton, Niels Vande Casteele. Factors Influencing Drug Disposition of Monoclonal Antibodies in Inflammatory Bowel Disease: Implications for Personalized Medicine. BioDrugs 2019; 33(5): 453 doi: 10.1007/s40259-019-00366-1
|
| 16 |
Rishabh Sehgal, Arthur Berg, Joseph I. Polinski, John P. Hegarty, Zhenwu Lin, Kevin J. McKenna, David B. Stewart, Lisa S. Poritz, Walter A. Koltun. Genetic Risk Profiling and Gene Signature Modeling to Predict Risk of Complications After IPAA. Diseases of the Colon & Rectum 2012; 55(3): 239 doi: 10.1097/DCR.0b013e31823e2d18
|
| 17 |
Nadan Rustemovic, Silvija Cukovic-Cavka, Marko Brinar, Davor Radić, Milorad Opacic, Rajko Ostojic, Boris Vucelic. A pilot study of transrectal endoscopic ultrasound elastography in inflammatory bowel disease. BMC Gastroenterology 2011; 11(1) doi: 10.1186/1471-230X-11-113
|
| 18 |
Themistocles Dassopoulos, Charles A. Sninsky. Optimizing Immunomodulators and Anti-TNF Agents in the Therapy of Crohn Disease. Gastroenterology Clinics of North America 2012; 41(2): 393 doi: 10.1016/j.gtc.2012.01.004
|
| 19 |
Nalini Raghavachari, Marjan Gucek. Omics for Personalized Medicine. 2013; : 3 doi: 10.1007/978-81-322-1184-6_1
|
| 20 |
Jacob L. McCauley, Maria T. Abreu. Genetics in Diagnosing and Managing Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2012; 41(2): 513 doi: 10.1016/j.gtc.2012.01.002
|
| 21 |
Suraya Zainul-Abidin, Derek F. Amanatullah, Michael B. Anderson, Matthew Austin, João Mauricio Barretto, Andrew Battenberg, Nicholas A. Bedard, Kerri Bell, Kier Blevins, John J. Callaghan, Li Cao, Laura Certain, Yuhan Chang, Jui Ping Chen, Zlatan Cizmic, Jonathan Coward, David E. DeMik, Efrain Diaz-Borjon, Mohammad Ali Enayatollahi, James E. Feng, Navin Fernando, Jeremy M. Gililland, Stuart Goodman, Susan Goodman, Max Greenky, Katherine Hwang, Richard Iorio, Vasili Karas, Riaz Khan, Matthew Kheir, Mitchell R. Klement, Setor K. Kunutsor, Ruben Limas, Ruben Alejandro Morales Maldonado, Jorge Manrique, Wadih Y. Matar, Lipalo Mokete, Ngai Nung, Christopher E. Pelt, Jurek R.T. Pietrzak, Ajay Premkumar, Alexander Rondon, Marisa Sanchez, Camila Novaes de Santana, Neil Sheth, Jasvinder Singh, Bryan D. Springer, Kae Sian Tay, Daniel Varin, Samuel Wellman, Lidong Wu, Chi Xu, Adolph J. Yates. General Assembly, Prevention, Host Related General: Proceedings of International Consensus on Orthopedic Infections. The Journal of Arthroplasty 2019; 34(2): S13 doi: 10.1016/j.arth.2018.09.050
|
| 22 |
Thomas Billiet, Paul Rutgeerts, Marc Ferrante, Gert Van Assche, Séverine Vermeire. Targeting TNF-α for the treatment of inflammatory bowel disease. Expert Opinion on Biological Therapy 2014; 14(1): 75 doi: 10.1517/14712598.2014.858695
|
| 23 |
Jennifer Jones, Juan Nicolás Peña-Sánchez. Who Should Receive Biologic Therapy for IBD?. Gastroenterology Clinics of North America 2014; 43(3): 425 doi: 10.1016/j.gtc.2014.05.004
|
| 24 |
Youlian Zhou, Hanchang He, Pu Wang, Ting Zhang, Minyi Lin, Hong Wang, Yuqiang Nie, Ye Chen. Infliximab for the treatment of Crohn’s disease. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1270 doi: 10.1097/MEG.0000000000000447
|
| 25 |
Michael Camilleri. The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nature Reviews Gastroenterology & Hepatology 2012; 9(3): 173 doi: 10.1038/nrgastro.2012.2
|
| 26 |
Philip J Smith, Gavin W Sewell, Adam P Levine. Endoscopy, but not as we know it. British Journal of Hospital Medicine 2011; 72(3): 174 doi: 10.12968/hmed.2011.72.3.174
|
| 27 |
Geert R D'Haens, Remo Panaccione, Peter D R Higgins, Severine Vermeire, Miquel Gassull, Yehuda Chowers, Stephen B Hanauer, Hans Herfarth, Daan W Hommes, Michael Kamm, Robert Löfberg, A Quary, Bruce Sands, A Sood, G Watermayer, Bret Lashner, Marc Lémann, Scott Plevy, Walter Reinisch, Stefan Schreiber, Corey Siegel, Stephen Targan, M Watanabe, Brian Feagan, William J Sandborn, Jean Frédéric Colombel, Simon Travis. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?. American Journal of Gastroenterology 2011; 106(2): 199 doi: 10.1038/ajg.2010.392
|
| 28 |
Christian Vázquez-Vázquez, Rosalinda Posadas-Sánchez, José Manuel Fragoso, Julian Ramírez-Bello, Marco Sánchez-Guerra, Citlalli Osorio-Yañez, Gilberto Vargas-Alarcón. IL-12BPolymorphisms Are Associated with the Presence of Premature Coronary Artery Disease and with Cardiovascular Risk Factors: The Genetics of Atherosclerotic Disease Mexican Study. DNA and Cell Biology 2020; 39(7): 1347 doi: 10.1089/dna.2020.5464
|